BofA lowered the firm's price target on Allegion to $150 from $157 and keeps a Neutral rating on the shares after the company reported Q1 results below the firm's forecast. The firm's estimates are largely unchanged, but it lowered its price target to reflect lower sector multiples, the analyst tells investors.
